As Omicron Wreaks Havoc on the Market, How Should Vaccine Makers Respond?

MillionaireTiger
2021-12-01

  • Covid vaccine makers' stocks soar on Omicron variant concerns last week.
  • Moderna Stock Slides After CEO Says Current Vaccines Will Struggle Against Omicron.

Shares of Covid-19 vaccine makers jumped on Friday, and again early on Monday, as global health officials sounded alarms about the new variant known as Omicron first identified in southern Africa. As Omicron Wreaks Havoc on the Market, How Should Vaccine Makers Respond?

$Pfizer(PFE)$

$Pfizer(PFE)$ closed out November trading with its best monthly advance in 30 years, as renewed virus fears revive the market’s focus on vaccine makers. The stock rose 2.5% to $53.73 in New York trading on Tuesday, ending the month with a 23% gain -- the most since 1991. Pfizer is up about 46% so far this year, with its dividend boosting the total return to more than 50%.

BioNTech and Moderna- the two messenger-RNA COVID vaccine giants - are racing to be the first companies to produce an effective vaccine against this latest strain.

$BioNTech SE(BNTX)$

BioNTech‘s American depositary receipt jumped 14.2% Friday but back to 351 on Tuesday.

$Moderna, Inc.(MRNA)$

Moderna‘s CEO predicted a “material drop” in the effectiveness of current vaccines against the Omicron variant and warned it could take months for drug companies to manufacture the new jabs at scale. Moderna stock was sliding on Tuesday.

$Novavax(NVAX)$

Shares of Novavax(NVAX), another company that is seeking approval from the United States' Food and Drug Administration for its Covid vaccine, were up 9% Friday but gave back a big chunk of those gains.

The stocks of two other vaccine manufacturers —Johnson & Johnson(JNJ) and AstraZeneca(AZN)— moved only modestly.

$Johnson & Johnson(JNJ)$

$AstraZeneca PLC(AZN)$

Investors are hoping that the major vaccine makers will be able to quickly update their Covid vaccines so that it can offer protection for the Omicron variant. 

Someone says,

Which side do you support? 

Which VACCINE stocks do you prefer? WHY?

Tell me your opinion! You may be rewarded with Tiger Coins💸💸💸

 

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

举报

评论（174）

  • 推荐
  • 最新
  • Joker_Smile
    ·2021-12-02
    both Pfizer-BioNtech and Moderna has done superb in the early stages of the pandemic in producing the vaccine. However, I think one, or more, companies will breakthough with a more compatible vaccine.
    回复
    举报
  • koolgal
    ·2021-12-02
    Vaccine is the Key to Freedom From Lockdowns! Leading the charge is Pfizer.It has 1st mover advantage as FDA approved it first. Revenue jumped 134% yoy & stock price skyrocketed to 44% YTD.Go Pfizer!
    回复
    举报
  • koolgal
    ·2021-12-02
    热烈欢迎两个最新的巨星葛兰素克莱恩&安培；Vir生物技术！抗Omicron的新药&；拯救世界！这是在测试阶段，但一旦抗病毒药物准备好，小心奥米克隆！Go GSK
    回复
    举报
    收起
  • KYHBKO
    ·2021-12-02
    我支持效果最好的疫苗。疫苗只是产品提供的一部分，因此，对一些人来说，还有其他赚钱的地方公司.我一直在看 $强生(JNJ)$
    回复
    举报
  • koolgal
    ·2021-12-03
    辉瑞在等待美国食品和药物管理局批准新冠肺炎药丸时处于领先地位！它也在竞相准备新的疫苗来对抗奥米克隆。它的股价在短短一个月内上涨了22%。加油，辉瑞！
    回复
    举报
  • Venus_M
    ·2021-12-02
    I prefer $Pfizer(PFE)$ .  All my jabs were Pfizer and so far so good.  It's a trusted brand and has been widely selected by others as their 1st choice for covid jabs.
    回复
    举报
  • 小小刀据大树
    ·2021-12-04
    $Moderna, Inc.(MRNA)$很强
    回复
    举报
  • YorkTurner
    ·2021-12-01
    LOL Im the bull of MRNA, just for the CEO's sincerity
    回复
    举报
  • NancyZhang
    ·2021-12-01
    The netizen is too funny! Due to the pandemic, vaccine stocks have positive trends definitely! Keep watching
    回复
    举报
  • MagicLea
    ·2021-12-01
    Actually I prefer the whole sector haha, the pandemic would continue at least 2y
    回复
    举报
  • RachelEuphemia
    ·2021-12-01
    No doubt I choose MRNA, the best and trusty one in my mind
    回复
    举报
  • mark01bravz
    ·2021-12-03
    no vaccine stock for me. only invested in crispr which is doing gene editing.
    回复
    举报
  • chefbean
    ·2021-12-03
    he e e
    回复
    举报
  • WARY
    ·2021-12-03
    good
    回复
    举报
  • Avik
    ·2021-12-02
    Moderna
    回复
    举报